Today, the Centers for Medicare & Medicaid Services released a redesigned version of the Drug Spending Dashboards. For the first time, the dashboards include year-over-year information on drug pricing and highlight which manufactures have been increasing their prices.
As the December 7th deadline grows closer for people with Medicare to change or choose their drug and health plan coverage for next year, the Centers for Medicare and Medicaid Services and its network of partners and advocates are available to assist with counseling and enrolling beneficiaries on their choices for 2012.
So far this year, more than 2.2 million people with Medicare have saved more than $1.2 billion on their prescriptions, for an average of $550 per person, the Centers for Medicare & Medicaid Services announced today.
The Centers for Medicare & Medicaid (CMS) has proposed revisions to the Medicare Advantage program and prescription drug benefit program (Part D) that would implement new benefits under the Affordable Care Act and increase patient protections.
Aggressive oversight and new improvement efforts have cut the number of improper fee-for-service Medicare claims payments by half in one year, from 10.1 percent in 2004 to 5.2 percent in 2005, a $9.5 billion reduction in improper payments, Centers for Medicare & Medicaid Services (CMS) Administrator Mark B. McClellan, M.D., Ph.D., announced today.
The Centers for Medicare & Medicaid Services (CMS) today announced a national strategy for monitoring claims for the drugs epoetin alfa (Epogen®) and darbepoetin alfa (Aranesp®) for anemia management in patients with End Stage Renal Disease (ESRD) and who are dialyzed in renal facilities.
The Centers for Medicare & Medicaid Services (CMS) expects to pay approximately $57.6 billion to 875,000 physicians and other health care professionals in 2006, according to a final rule released today that will update payment rates and revise payment policies under the Medicare Physician Fee Schedule.